Siemens Healthcare in partnership with Kolkata based EKO Diagnostic (EDPL) is planning to set up a cyclotron facility to manufacture Positron Emission Tomography (PET) biomarkers to diagnose diseases such as cancer, cardiac and certain neurology disorders. On 9 December 2009, both the partners signed an agreement in this regard.
Siemens intends to set up five such cyclotron facilities across India by 2014. Each facility is estimated to cost $3-5 million (approx 13.95-23.25 crore) while EDPL is likely to invest close to Rs 50 crore for the required infrastructure.
The first facility is likely to be located in the Nuclear Medicine Department at Rajarhat in West Bengal and it is expected to be ready by June 2010.
Siemens is expected to undertake the production and distribution of PET biomarkers, and the necessary infrastructure is to be provided by EDPL. PET biomarkers manufactured at the Nuclear Medicine department are likely to be distributed to hospitals, clinics and research institutions in the city and eastern and north eastern region of India.
